Litigation Details for BAUSCH HEALTH IRELAND LIMITED v. AUROBINDO PHARMA LIMITED (D.N.J. 2023)
✉ Email this page to a colleague
BAUSCH HEALTH IRELAND LIMITED v. AUROBINDO PHARMA LIMITED (D.N.J. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-01-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2023-10-30 |
| Cause | 35:271 Patent Infringement | Assigned To | Stanley R. Chesler |
| Jury Demand | None | Referred To | Jessica S. Allen |
| Patents | 10,011,637; 7,041,786; 9,610,321; 9,616,097; 9,919,024; 9,925,231 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in BAUSCH HEALTH IRELAND LIMITED v. AUROBINDO PHARMA LIMITED
The small molecule drug covered by the patents cited in this case is ⤷ Sign Up .
Details for BAUSCH HEALTH IRELAND LIMITED v. AUROBINDO PHARMA LIMITED (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2023-01-12 | 1 | Complaint | the ’097 patent”), 9,919,024 (“the ’024 patent”), 9,925,231 (“the ’231 patent”), 10,011,637 (“the ’637…’786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent, the ’637 patent, the…’786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent, the ’637 patent, the…786 patent, the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent, the ’637 patent, the …to the ’321 patent, the ’097 patent, the ’024 patent, the ’231 patent, or the ’637 patent. 34 | External link to document |
| 2023-10-30 | 34 | Order of Dismissal | certification to U.S. Patent Nos. 7,041,786, 9,610,321, 9,616,097, 9,919,024, 9,925,231, 10,011,637, 11,142,549…2023 30 October 2023 2:23-cv-00170 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
